Colorectal cancer organoid drug sensitivity evaluation and prognosis prediction system, method and equipment

The invention belongs to the technical field of drug sensitivity detection, and discloses a colorectal cancer organoid drug sensitivity evaluation and prognosis prediction system, method and equipment, the colorectal cancer organoid drug sensitivity evaluation system comprises: a standard establishm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHEN ZHENBANG, DONG SHUMIN, WANG SHIJIE, XUE WEISONG, TANG YUTING, YAN JUN, WANG TING, ZHANG BIAO
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA HUMAN NECESSITIES HYGIENE INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention belongs to the technical field of drug sensitivity detection, and discloses a colorectal cancer organoid drug sensitivity evaluation and prognosis prediction system, method and equipment, the colorectal cancer organoid drug sensitivity evaluation system comprises: a standard establishment module, which is used for establishing an organoid drug sensitivity evaluation standard, the chemosensitivity and the non-sensitivity are distinguished based on drug sensitivity evaluation criteria; and the standard verification module is used for verifying the established organoid drug sensitivity evaluation standard. The colorectal cancer organoid drug sensitivity evaluation method comprises the following steps: establishing an organoid drug sensitivity evaluation standard, and distinguishing chemosensitivity and non-sensitivity based on the drug sensitivity evaluation standard; and verifying the established organoid drug sensitivity evaluation standard. The method can quantitatively, directly and individuall